Brooks Laboratories [BROOKS] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Brooks Laboratories Ltd.

NSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Brooks Laboratories Ltd. wins in 6 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Brooks Laboratories Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 8.34 67.11 Brooks Laboratories Ltd.
Price-to-Book Ratio 1.56 10.82 Brooks Laboratories Ltd.
Debt-to-Equity Ratio 6.77 0.58 Divi's Laboratories Ltd.
PEG Ratio -0.04 4.63 Divi's Laboratories Ltd.
EV/EBITDA 25.01 48.63 Brooks Laboratories Ltd.
Profit Margin (TTM) 24.32% 24.04% Brooks Laboratories Ltd.
Operating Margin (TTM) 2.05% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 2.05% 29.65% Divi's Laboratories Ltd.
Return on Equity -10.16% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) -8.06% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $15.98M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -54.45% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 2.03 16.18 Brooks Laboratories Ltd.
Enterprise Value $1.95B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 2.20 15.86 Brooks Laboratories Ltd.
Gross Profit Margin (TTM) 45.68% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $30 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $7.35 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.81 0.19 Divi's Laboratories Ltd.

Brooks Laboratories Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

BROOKS
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Brooks Laboratories Ltd.-3.95%3.55%18.08%4.21%-34.87%-17.04%
Divi's Laboratories Ltd.0.67%-3.25%-0.65%4.12%1.88%3.66%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Brooks Laboratories Ltd.-54.45%6.49%-35.78%-3.14%87.61%87.61%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Brooks Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricBROOKSDIVISLAB
Market Information
Market Cap i₹1.90B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i124,101253,443
90 Day Avg. Volume i195,493283,911
Last Close₹64.40₹6,576.50
52 Week Range₹36.30 - ₹164.02₹5,636.50 - ₹7,071.50
% from 52W High-60.74%-7.00%
All-Time High₹198.86 (Jan 06, 2025)₹7,071.50 (Jul 08, 2025)
% from All-Time High-67.62%-7.00%
Growth Metrics
Quarterly Revenue Growth-0.57%0.12%
Quarterly Earnings Growth-0.57%-0.01%
Financial Health
Profit Margin (TTM) i0.24%0.24%
Operating Margin (TTM) i0.02%0.30%
Return on Equity (TTM) i-0.10%0.15%
Debt to Equity (MRQ) i6.770.58
Cash & Liquidity
Book Value per Share (MRQ)₹39.30₹580.95
Cash per Share (MRQ)₹0.36₹122.95
Operating Cash Flow (TTM) i₹-42,666,000₹19.67B
Levered Free Cash Flow (TTM) i₹-99,670,000₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Brooks Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricBROOKS (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i8.3467.11
Forward P/E i10.5553.75
PEG Ratio i-0.044.63
Price to Sales (TTM) i2.0316.18
Price to Book (MRQ) i1.5610.82
Market Capitalization
Market Capitalization i₹1.90B₹1.69T
Enterprise Value i₹1.95B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i2.2015.86
Enterprise to EBITDA i25.0148.63
Risk & Other Metrics
Beta i0.810.19
Book Value per Share (MRQ) i₹39.30₹580.95

Financial Statements Comparison: Brooks Laboratories Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBROOKS (2025)DIVISLAB (2025)
Revenue/Sales i821.86M93.25B
Cost of Goods Sold i593.60M38.70B
COGS % of Revenue i72.2%41.5%
Gross Profit i228.25M54.55B
Gross Margin i27.8%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i65.27M25.71B
Operating Margin i7.9%27.6%
EBITDA i-42.57M33.19B
EBITDA Margin i-5.2%35.6%
Pre-Tax Income i-97.92M29.16B
Pre-Tax Income % of Revenue i-11.9%31.3%
Income Tax i1.75M7.25B
Income Tax % of Revenue i0.2%7.8%
Net Income (Profit) i-99.67M21.91B
Profit Margin i-12.1%23.5%

Balance Sheet & Liquidity Metrics

MetricBROOKS (2025)DIVISLAB (2025)
Cash & Equivalents i434,0004.15B
Total Current Assets i338.77M100.81B
Total Current Assets % of Revenue i41.2%108.1%
Total Current Liabilities i228.44M14.52B
Total Current Liabilities % of Revenue i27.8%15.6%
Long-Term Debt i13.70M20.00M
Long-Term Debt % of Revenue i1.7%0.0%
Total Shareholders Equity i981.04M149.69B
Retained Earnings i-486.52M134.00B
Retained Earnings % of Revenue i-59.2%143.7%
Property, Plant & Equipment i3.45M3.19B

Cash Flow Statement Comparison

MetricBROOKS (2025)DIVISLAB (2025)
Operating Cash Flow i-42.67M19.67B
Operating Cash Flow % of Revenue i-5.2%21.1%
Capital Expenditures i-9.13M-14.38B
Free Cash Flow i15.98M2.15B
FCF Margin i1.9%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBROOKSDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i29.46M265.47M
Float Shares i13.27M117.72M
% Held by Insiders i56.02%52.04%
% Held by Institutions i9.90%28.65%
% Held by Public i34.08%19.31%

Dividend Analysis & Yield Comparison: Brooks Laboratories Ltd. vs Divi's Laboratories Ltd.

MetricBROOKSDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025